Cellyan Biotechnology receives Nasdaq bid price deficiency notice [Seeking Alpha]
Cellyan Biotechnology Co., Ltd - Class A Ordinary Shares (HKPD)
Company Research
Source: Seeking Alpha
The deficiency arose after the company's shares traded below $1 for 30 consecutive business days from November 26, 2025 to January 9, 2026. Cellyan has been granted a 180-day compliance period, until July 13, 2026, to regain compliance. The company may pursue measures such as a reverse share split if needed and could qualify for an additional 180-day grace period. Newsletters for Every Investor Get daily, sector-specific newsletters packed with expert insights, fresh ideas, and new opportunities. Subscribe to Newsletters Sign Up More on Cellyan Biotechnology Co., Ltd Seeking Alpha's Quant Rating on Cellyan Biotechnology Co., Ltd Financial information for Cellyan Biotechnology Co., Ltd
Show less
Read more
Impact Snapshot
Event Time:
HKPD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
HKPD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
HKPD alerts
High impacting Cellyan Biotechnology Co., Ltd - Class A Ordinary Shares news events
Weekly update
A roundup of the hottest topics
HKPD
News
- Cellyan Biotechnology Co., Ltd Receives Nasdaq Notice of Bid Price DeficiencyGlobeNewswire
- Hong Kong Pharma Digital Announced Results of 2025 Annual Meeting of Stockholders [Yahoo! Finance]Yahoo! Finance
- Hong Kong Pharma Digital Announced Results of 2025 Annual Meeting of StockholdersGlobeNewswire
- Eddid Financial Celebrates 10th Anniversary with Grand LuncheonPR Newswire
HKPD
Sec Filings
- 1/16/26 - Form 6-K
- 12/17/25 - Form 6-K
- 11/24/25 - Form 6-K
- HKPD's page on the SEC website